---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-025438"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2025-08-26T23:59:59+00:00"
generated_at: "2026-05-17T09:56:54.573720+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BriaCell Therapeutics announces 1-for-10 reverse stock split effective August 25, 2025 to maintain Nasdaq listing

## Summary
- Share consolidation of 1 post-split share for every 10 pre-split shares, effective August 25, 2025.
- Post-consolidation common shares trade on Nasdaq (BCTX) and TSX (BCT) under same symbols.
- Consolidation intended to ensure continued compliance with Nasdaq listing requirements.
- No fractional shares issued; fractions less than 0.5 cancelled, 0.5 or greater rounded up to one share.
- Outstanding convertible securities' exercise/conversion prices proportionately adjusted.

## SEC filing metadata
- accession: 0001641172-25-025438
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2025-08-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000164117225025438/0001641172-25-025438-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000164117225025438/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-025438
- JSON: https://secwatch.observer/filing/0001641172-25-025438.json
- Plain text: https://secwatch.observer/filing/0001641172-25-025438.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.